VALUE-ADDED BENEFITS FOR HOSPITALS
THE QUEST MPS®3 ND TECHNOLOGY CAN BENEFIT HOSPITALS AT MULTIPLE LEVELS THROUGH THE NEXT GENERATION OF MYOCARDIAL PROTECTION. THE ADVANCED TECHNOLOGY CAN REDUCE HOSPITALS COSTS AND SIMPLIFY PHARMACY MANAGEMENT.


REDUCE PHARMACY AND HOSPITAL COSTS2
Investing in the Quest MPS 3 ND System, hospitals can benefit by:
• Eliminating the purchasing of compound cardioplegia
• Reducing waste
• Improving patient outcomes
The innovative design of the Quest MPS 3 ND System allows drawing drugs directly from the vial, which eliminates the need for compounding multi-ingredient cardioplegia solutions and can reduce waste.
With the superior myocardial protection that microplegia offers using the Quest MPS Technology patients can benefit from a quicker recovery and less time in ICU.2


Reduction
in adverse events


Patients
1 day less


Discharge
1 day earlier


Reduction
in medication costs


Reduction
in hospital costs


Better
patient outcomes


